Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2006-11-29
2010-10-26
Patel, Niketa I (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C435S007200, C435S007920, C530S388850, C514S654000
Reexamination Certificate
active
07822474
ABSTRACT:
Methods and kits are provided for determining an increased likelihood of the occurrence of a cardiac arrhythmia, myocardial ischemia, congestive heart failure and other diseased conditions of the heart. The methods and kits comprise measuring serum NGF levels in a subject and detecting increases in NGF levels over baseline. The methods may further comprise initiating preventive therapy in response to a detected increase in serum NGF levels.
REFERENCES:
patent: 4026300 (1977-05-01), DeLuca et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4573481 (1986-03-01), Bullara
patent: 4774967 (1988-10-01), Zanakis et al.
patent: 4919140 (1990-04-01), Borgens et al.
patent: 5147294 (1992-09-01), Smith et al.
patent: 5199428 (1993-04-01), Obel et al.
patent: 5203326 (1993-04-01), Collins
patent: 5224477 (1993-07-01), Itoh
patent: 5366487 (1994-11-01), Adams et al.
patent: 5447520 (1995-09-01), Spano et al.
patent: 5471991 (1995-12-01), Shinwar
patent: 5578061 (1996-11-01), Stroetmann et al.
patent: 5658318 (1997-08-01), Stroetmann et al.
patent: 5698549 (1997-12-01), Steers et al.
patent: 5700282 (1997-12-01), Zabara
patent: 5921940 (1999-07-01), Verrier et al.
patent: 6272377 (2001-08-01), Sweeney et al.
patent: 6308094 (2001-10-01), Shusterman et al.
patent: 6351668 (2002-02-01), Chen
patent: 6353757 (2002-03-01), Chen
patent: 6398800 (2002-06-01), Chen
patent: 6516219 (2003-02-01), Street
patent: 6521462 (2003-02-01), Tanouye et al.
patent: 6593341 (2003-07-01), Feller et al.
patent: 6885888 (2005-04-01), Rezai
patent: 6950752 (2005-09-01), Friend et al.
patent: 7142911 (2006-11-01), Boileau et al.
patent: 7257439 (2007-08-01), Llinas
patent: 7266410 (2007-09-01), Chen
patent: 2003/0118652 (2003-06-01), Kelly et al.
patent: 2003/0216349 (2003-11-01), Belardinelli et al.
patent: 2004/0006264 (2004-01-01), Mojarradi et al.
patent: 2004/0014639 (2004-01-01), Belyea et al.
patent: 2004/0054177 (2004-03-01), Otake et al.
patent: 2005/0074821 (2005-04-01), Wild et al.
patent: 0882452 (1998-09-01), None
patent: WO 99 39624 (1999-08-01), None
patent: PCT/US00/12367 (2000-05-01), None
patent: PCT/AU/00/01362 (2000-11-01), None
patent: PCT/US01/05777 (2001-02-01), None
patent: WO 02 18436 (2002-03-01), None
Adrian, et al.: Discharges in mammalian sympathetic nerves,J Physiol1932;74:115-133.
Akingba, et al.: Application of nanoelectrodes in recording biopotentials.Nanotechnology,2003. IEEE-NANO 2003;2:870-874.
Akira, et al: Induction of atrial fibrillation and nerve sprouting by prolonged left atrial pacing in dogs.PACE2003;26:2247-2252.
Anthonio et al., “β-Adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of β1-adrenoceptor density,” International Journal of Cardiology, 2000, pp. 137-141, vol. 72,Elsevier Science Ireland Ltd.,Ireland.
Antzelevitch, “Tpeak-Tend interval as an index of transmural dispersion of repolarization,”European Journal of Clinical Investigation,2001, pp. 555-557, vol. 31, BlackwellScienceLtd.
Armour JA: Activity of in situ middle cervical ganglion neurons in dogs, using extracellular recording techniques.Can.J Physiol Pharmacol.1985;63:704-716.
Armour, et al.: Activity of canine in situ left atrial ganglion neurons.Am.J Physiol1990;259:H1207-H1215.
Armour, et al.: Activity of in vivo canine ventricular neurons.Am.J Physiol1990;258:H326-H336.
Arntz, et al.: Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation.Circulation1993;88:2284-89.
Aronow, et al.: Circadian variation of primary cardiac arrest or sudden cardiac death in patients aged 62 to 100 years (mean 82).Am J Cardiol1993;71:1455-1456.
Aronow, et al.: Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias.Am J Cardiol1994;74:819-821.
Athill, et al.: Influence of wavefront dynamics on transmembrane potential characteristics during atrial fibrillation.J Cardiovasc Electrophysiol2000; 11:913-921.
Barbacid M: Nerve growth factor: a tale of two receptors.Oncogene1993;8:2033-2042.
Barber, et al.: Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction.Circulation1985;72:623-631.
Barhanin, et al.: KvLQT1 and IsK (minK) proteins associate to form the 1(Ks) cardiac potassium current.Nature1996;384:78-80.
Barrett, et al.: What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes?Circ.Res.2003;92:1330-1336.
Bartels et al., “Influence of Myocardial Ischemia and Reperfusion on β-Adrenoceptor Subtype Expression,”Journal of Cardiovascular Pharmacology,1998, pp. 484-487, vol. 31, Lippincott-Raven Publishers, Philadelphia, PA, USA.
Bengel, et al.: Myocardial efficiency and sympathetic reinnervation after orthotopic heart transplantation: a noninvasive study with positron emission tomography.Circulation2001;103:1881-1886.
Benjamin, et al.: Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.Circulation1998;98:946-952.
Bers, “Calcium and Cardiac Rhythms: Physiological and Pathophysiological,”Circulation Research,2002, pp. 14-17, vol. 90, American Heart Association, USA.
Blakey, et al.: Sudden, unexpected death in cardiac transplant recipients: an autopsy study.J Heart Lung Transplant2001;20:229(abstract).
Boczek-Funcke, et al.: Classification of preganglionic neurones projecting into the cat cervical sympathetic trunk.J Physiol1992;453:319-339.
Bonnemeier, et al.: Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction.J Am Coll Cardiol2001;37:44-50.
Bosch et al., “β3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium currentIKsin guinea pig ventricular myocytes,”Cardiovascular Research,2002, pp. 393-403, vol. 56, ElsevierScienceB.V.
Bristow et al., “Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts,”The New England Journal of Medicine,Jul. 22, 1982, pp. 205-211, vol. 307, No. 4, Massachusetts Medical Society, Boston, MA, USA.
Bristow et al., “Reduced β1Receptor Messenger RNA Abundance in the Failing Human Heart,”The Journal of Clinical Investigation,Dec. 1993, pp. 2737-2745, vol. 92, The American Society for Clinical Investigation, Inc., USA.
Bristow et al., “β1and β2-Adrenergic-Receptor Subpopulations in Nonfailing and Failing Human Ventricular Myocardium: Coupling of Both Receptor Subtypes to Muscle Contraction and Selective β1-Receptor Down-Regulation in Heart Failure,”Circulation Research,Sep. 1986, pp. 297-309, vol. 59, No. 3, American Heart Association, USA.
Bristow et al., β1and β2-Adrenergic-Receptor-Mediated Adenylate Cyclase Stimulation in Nonfailing and Failing Human Ventricular Myocardium, Molecular Pharmacology, Mar. 1989, pp. 295-303, vol. 35, No. 3,American Society for Pharmacology and Experimental Therapeutics,Williams & Wilkins, USA.
Brodde et al., “Adrenergic and Muscarinic Receptors in the Human Heart,” Pharmacological Reviews, 1999, pp. 651-689,0031-6997/99/5104-0651,The American Society for Pharmacology and Experimental Therapeutics,USA.
Brodde et al., “β-Adrenoceptors in the transplanted human heart: unaltered β-adrenoceptor density, but increased proporation of β2-adrenoceptors with increasing posttransplant time,”Naunyn-Schmiedeberg's Arch. Pharmacol.,1991, pp. 430-436, vol. 344, Springer-Verlag.
Brodde et al.: Beta-adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of betal-adrenoceptor density.Int J Cardiol2000;72:137-41.
Burke, et al.: Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans.Circulation1995;91:72-78.
Cao JM, et al.: Nerve sprouting and sudden car
Cedars-Sinai Medical Center
Davis , Wright, Tremaine, LLP
Levy Seth D.
Narayanaswamy Shubatra
Patel Niketa I
LandOfFree
Methods for the prediction of arrhythmias and prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the prediction of arrhythmias and prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the prediction of arrhythmias and prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4178192